Literature DB >> 24067789

The MyD88 rs6853 and TIRAP rs8177374 polymorphic sites are associated with resistance to human pulmonary tuberculosis.

R Capparelli1, F De Chiara, A Di Matteo, C Medaglia, D Iannelli.   

Abstract

Toll-like receptors recognize several components of Mycobacterium tuberculosis, the main causative agent of tuberculosis. The signaling pathways leading to activation of the immune response require the MyD88 and TIRAP genes. The hypothesis that polymorphic variants of these genes influenced resistance to pulmonary tuberculosis was tested by a case-control study (400 cases and 400 controls). Heterozygosity at the polymorphic sites MyD88 rs6853 (alleles: A, G) or TIRAP rs8177374 (S180L) (alleles: C, T) is associated with resistance to pulmonary tuberculosis (P: 7.8 × 10(-8) and 2 × 10(-6), respectively). Double heterozygosity confers higher protection levels (P: 10(-14) to 2 × 10(-16)). The logistic regression model displayed that the double homozygous genotype GG/TT predisposes to the disease (odds ratio (OR): 5.78) and the AG/TT genotype combination neutralizes the protective activity exerted by AG (OR: 3.05). The same model showed that the risk of developing the disease increases with age from 31-40 years to 71-80 years (OR: 1.32-13.59).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067789     DOI: 10.1038/gene.2013.48

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  8 in total

Review 1.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

2.  Association of the TLR1 variant rs5743557 with susceptibility to tuberculosis.

Authors:  Miaomiao Zhang; Jing Wang; Yu Wang; Shouquan Wu; Andrew J Sandford; Jun Luo; Jian-Qing He
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

Review 3.  The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis.

Authors:  Jialu Ma; Shasha Zhao; Xiao Gao; Rui Wang; Juan Liu; Xiangmei Zhou; Yang Zhou
Journal:  Pathogens       Date:  2021-01-25

4.  The -938C>A Polymorphism in MYD88 Is Associated with Susceptibility to Tuberculosis: A Pilot Study.

Authors:  Kalliopi Aggelou; Elena Konstantina Siapati; Irini Gerogianni; Zoe Daniil; Konstantinos Gourgoulianis; Ioannis Ntanos; Emmanouel Simantirakis; Elias Zintzaras; Vassiliki Mollaki; George Vassilopoulos
Journal:  Dis Markers       Date:  2016-12-29       Impact factor: 3.434

Review 5.  Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies.

Authors:  Imène Belhaouane; Eik Hoffmann; Mathias Chamaillard; Priscille Brodin; Arnaud Machelart
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 6.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

7.  Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.

Authors:  Daniel T Barratt; Pål Klepstad; Ola Dale; Stein Kaasa; Andrew A Somogyi
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

8.  A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling.

Authors:  Clíona Ní Cheallaigh; Frederick J Sheedy; James Harris; Natalia Muñoz-Wolf; Jinhee Lee; Kim West; Eva Palsson McDermott; Alicia Smyth; Laura E Gleeson; Michelle Coleman; Nuria Martinez; Claire H A Hearnden; Graham A Tynan; Elizabeth C Carroll; Sarah A Jones; Sinéad C Corr; Nicholas J Bernard; Mark M Hughes; Sarah E Corcoran; Mary O'Sullivan; Ciara M Fallon; Hardy Kornfeld; Douglas Golenbock; Stephen V Gordon; Luke A J O'Neill; Ed C Lavelle; Joseph Keane
Journal:  Immunity       Date:  2016-02-16       Impact factor: 31.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.